mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.3 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.049 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.3 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.4 |
mRNA |
necrostatin-7 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |
mRNA |
shikonin |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |